3D Imaging and Visualization of Gene Therapies in Whole Animals

Download Tech Note

Supporting Clinical Research With Core Lab Excellence

Learn More

Discover Deeper Insights with Advanced Image Analytics

Learn More

Gain New Insights in Early Drug Discovery

Learn More

 TauIQ launches in Invicro’s Core Lab alongside seminal publication in the Journal of Nuclear Medicine

TauIQ – A canonical image based algorithm to quantify tau PET scans was recently published in The Journal of Nuclear Medicine (JNM). In conjunction with this publication, Invicro has launched 21 CFR Part 11 compliant TauIQ services in its Core Lab as part of its expanded IQ-Analytics Platform, which includes AmyloidIQ and DaTIQ.

This publication highlights:

  • TauL as calculated by TauIQ provides a superior approach for the quantification of tau PET data.
  • Provides a substantial improvement in power for longitudinal analyses and the early detection of tau deposition.
  • Based on improvement in power for longitudinal analysis, It should have significant value for clinical imaging trials in AD that are investigating the attenuation of tau deposition with novel therapies.

VIEW PRESS RELEASE

SUPPORTING
ALL DRUG
DISCOVERY &
DEVELOPMENT
PHASES

DRUG
DISCOVERY
EARLY
CLINICAL
LATE
PHASE
  • 3,000+ Research Trials Managed
  • 1,500+ Peer-reviewed Publications
  • ~25,000,000 (DICOM) Images Processed
  • 800+ Molecules Labeled

New Webinar Now Available On-Demand

EXPLORER as a Transformational Imaging Technology for Drug Development

Watch Now

Oncology Webinar Series

Gain insights on ground-breaking techniques and imaging methods in preclinical through late phase oncology studies.

Watch Now